Edition:
United Kingdom

Aerie Pharmaceuticals Inc (AERI.OQ)

AERI.OQ on NASDAQ Stock Exchange Global Market

38.22USD
14 Dec 2018
Change (% chg)

$-0.79 (-2.03%)
Prev Close
$39.01
Open
$39.00
Day's High
$39.04
Day's Low
$38.09
Volume
176,720
Avg. Vol
165,444
52-wk High
$74.75
52-wk Low
$38.09

Chart for

About

Aerie Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. The Company's product candidates include Rhopressa (netarsudil ophthalmic solution) 0.02%... (more)

Overall

Beta: 1.06
Market Cap(Mil.): $1,913.33
Shares Outstanding(Mil.): 36.34
Dividend: --
Yield (%): --

Financials

  AERI.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -3.26 -- --
ROI: -51.22 9.01 14.96
ROE: -128.08 10.15 16.52

Earnings vs. Estimates